Among 2 analysts covering Insulet (NASDAQ:PODD), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Insulet had 3 analyst reports since October 11, 2018 according to SRatingsIntel. The company was maintained on Wednesday, January 2 by Morgan Stanley. The rating was maintained by Morgan Stanley on Thursday, October 11 with “Equal-Weight”. See Insulet Corporation (NASDAQ:PODD) latest ratings:

02/01/2019 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $105 New Target: $90 Maintain
28/11/2018 Broker: UBS Rating: Buy New Target: $105 Initiates Coverage On
11/10/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $96 New Target: $105 Maintain

Bedrijfstakpensioenfonds Voor De Media Pno decreased Facebook Inc (FB) stake by 6.21% reported in 2018Q3 SEC filing. Bedrijfstakpensioenfonds Voor De Media Pno sold 10,000 shares as Facebook Inc (FB)’s stock declined 13.60%. The Bedrijfstakpensioenfonds Voor De Media Pno holds 151,000 shares with $24.83M value, down from 161,000 last quarter. Facebook Inc now has $413.73B valuation. The stock decreased 2.38% or $3.51 during the last trading session, reaching $143.96. About 6.80 million shares traded. Facebook, Inc. (NASDAQ:FB) has declined 21.26% since January 29, 2018 and is downtrending. It has underperformed by 21.26% the S&P500. Some Historical FB News: 25/04/2018 – FACEBOOK INC FB.O – CFO WEHNER SAYS THERE IS ‘POTENTIAL FOR SOME IMPACT ON REVENUE’ FROM EU LAW GDPR – CONF CALL; 09/05/2018 – Swedbank Adds Lam Research, Cuts Facebook: 13F; 02/05/2018 – Techmeme: Sources: Google is building Arcade, a social-gaming startup led by 21yo ex-Facebook staffer Michael Sayman, which wil; 17/03/2018 – Facebook bans political data company Cambridge Analytica; 10/04/2018 – ZUCKERBERG SAYS IT ‘DOESN’T FEEL LIKE’ FACEBOOK HAS A MONOPOLY; 18/05/2018 – A Risk-Management Plan for Facebook — Barron’s Blog; 29/03/2018 – Facebook’s Former Employees Open Up About the Data Scandal; 21/03/2018 – ZUCKERBERG SAYS FACEBOOK WILL INVESTIGATE ALL APPS THAT HAD ACCESS TO LARGE AMOUNTS OF DATA BEFORE 2014 CHANGES; 18/03/2018 – Users are getting the message that information they post on Facebook can be used in ways they did not intend, and usage is starting to decline; 19/03/2018 – CONNECTICUT ATTORNEY GENERAL SAYS IN STATEMENT OFFICE IS INITIATING INQUIRY INTO FACEBOOK DATA POLICIES FOLLOWING CAMBRIDGE ANALYTICA REPORTS

Analysts await Facebook, Inc. (NASDAQ:FB) to report earnings on January, 30 after the close. They expect $2.17 EPS, down 1.36% or $0.03 from last year’s $2.2 per share. FB’s profit will be $6.24 billion for 16.59 P/E if the $2.17 EPS becomes a reality. After $1.76 actual EPS reported by Facebook, Inc. for the previous quarter, Wall Street now forecasts 23.30% EPS growth.

Investors sentiment increased to 1.13 in Q3 2018. Its up 0.04, from 1.09 in 2018Q2. It improved, as 123 investors sold FB shares while 598 reduced holdings. 154 funds opened positions while 661 raised stakes. 1.61 billion shares or 3.39% less from 1.66 billion shares in 2018Q2 were reported. Alpha Cubed Lc stated it has 0.52% of its portfolio in Facebook, Inc. (NASDAQ:FB). Cedar Hill Assocs Lc holds 0.77% or 20,919 shares. Regent Investment has 2.96% invested in Facebook, Inc. (NASDAQ:FB). Eagleclaw Managment Ltd Com holds 0.16% or 2,273 shares. Atwood & Palmer invested in 1,588 shares or 0.03% of the stock. Moreover, Ballentine Llc has 0.16% invested in Facebook, Inc. (NASDAQ:FB). Wealth Enhancement Advisory Ltd Limited Liability Company has 0.2% invested in Facebook, Inc. (NASDAQ:FB) for 22,546 shares. Parthenon Limited Liability Corp holds 1.7% or 47,129 shares in its portfolio. Hallmark Cap Mgmt owns 1,995 shares for 0.04% of their portfolio. Moors Cabot owns 29,845 shares for 0.6% of their portfolio. Cambridge Research Advisors Inc invested in 277,523 shares. Tiger Mgmt Ltd Liability reported 172,810 shares. Css Ltd Liability Corp Il has 1,800 shares. Ami Invest Management invested in 1.83% or 21,473 shares. Moreover, Preferred Ltd Liability Co has 0.02% invested in Facebook, Inc. (NASDAQ:FB) for 302 shares.

More notable recent Facebook, Inc. (NASDAQ:FB) news were published by: which released: “Facebook (FB) stock could have big upside following Q4 earnings – Nasdaq” on January 26, 2019, also with their article: “Should You Buy Facebook (FB) Stock Ahead of Q4 Earnings? – Nasdaq” published on January 24, 2019, published: “Facebook (FB) to Report Q4 Earnings: What’s in the Cards? – Nasdaq” on January 25, 2019. More interesting news about Facebook, Inc. (NASDAQ:FB) were released by: and their article: “Here’s Why Facebook (FB) Stock Looks Like a Buy – Nasdaq” published on January 02, 2019 as well as Nasdaq.com‘s news article titled: “Tech Stocks’ Earnings Lineup for Jan 30: CHKP, FB & More – Nasdaq” with publication date: January 29, 2019.

Among 15 analysts covering Facebook (NASDAQ:FB), 10 have Buy rating, 0 Sell and 5 Hold. Therefore 67% are positive. Facebook had 19 analyst reports since September 4, 2018 according to SRatingsIntel. The stock has “Buy” rating by Argus Research on Wednesday, October 3. Credit Suisse maintained Facebook, Inc. (NASDAQ:FB) on Monday, October 8 with “Outperform” rating. The firm earned “Overweight” rating on Wednesday, October 31 by Morgan Stanley. Citigroup maintained the stock with “Buy” rating in Wednesday, October 31 report. The stock of Facebook, Inc. (NASDAQ:FB) has “Neutral” rating given on Tuesday, September 4 by Moffett Nathanson. On Wednesday, October 31 the stock rating was maintained by Nomura with “Neutral”. The rating was maintained by Canaccord Genuity on Wednesday, October 31 with “Buy”. As per Wednesday, October 24, the company rating was maintained by Bank of America. The company was maintained on Thursday, December 20 by Tigress Financial. The stock of Facebook, Inc. (NASDAQ:FB) has “Overweight” rating given on Wednesday, October 31 by KeyBanc Capital Markets.

Since July 30, 2018, it had 0 insider buys, and 52 sales for $576.42 million activity. Shares for $495,309 were sold by Cox Christopher K on Monday, November 5. Zuckerberg Mark had sold 137,400 shares worth $23.76 million on Wednesday, August 1. Schroepfer Michael Todd sold $6.33 million worth of Facebook, Inc. (NASDAQ:FB) on Tuesday, September 11. The insider Sandberg Sheryl sold 55,000 shares worth $7.97M. Another trade for 750 shares valued at $120,000 was made by Stretch Colin on Wednesday, October 17. $1.72M worth of Facebook, Inc. (NASDAQ:FB) shares were sold by Wehner David M.. FISCHER DAVID B. also sold $392,937 worth of Facebook, Inc. (NASDAQ:FB) on Monday, October 29.

Insulet Corporation, a medical device company, develops, makes, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company has market cap of $4.51 billion. The firm offers Omnipod Insulin Management System , which consists of the OmniPod, an easy-to-use continuous insulin delivery system; and Personal Diabetes Manager, a handheld wireless device. It currently has negative earnings. It also customizes the Omnipod System technology platform for the delivery of subcutaneous drugs across various therapeutic areas.

The stock decreased 2.61% or $2.05 during the last trading session, reaching $76.39. About 170,584 shares traded. Insulet Corporation (NASDAQ:PODD) has risen 20.02% since January 29, 2018 and is uptrending. It has outperformed by 20.02% the S&P500. Some Historical PODD News: 14/03/2018 lnsulet to Share Omnipod Clinical Data at Three Major European National Diabetes Congresses; 01/05/2018 – INSULET ESTABLISHES PARTNERSHIPS TO SUPPORT EUROPEAN EXPANSION; 28/03/2018 – INSULET CORP PODD.O : COWEN AND COMPANY RAISES TARGET PRICE TO $100 FROM $90; 25/04/2018 – Hartford Growth Opportunities HLS Adds Insulet; 03/05/2018 – Insulet Reports First Quarter 2018 Revenue of $123.6 Million, Up 21% Year-Over-Year, and Gross Margin of 61.4%, Up 300 Basis; 04/05/2018 – INSULET CORP PODD.O : BMO RAISES TARGET PRICE TO $100 FROM $90; 25/04/2018 – Hartford Growth Opportunities Adds Insulet, Exits Booking; 01/05/2018 – INSULET ESTABLISHES TWO SIGNIFICANT COMMERCIAL PARTNERSHIPS TO; 29/05/2018 – Insulet Presenting at Conference Jun 12; 03/05/2018 – lnsulet Reports First Quarter 2018 Revenue of $123.6 Million, Up 21% Year-Over-Year, and Gross Margin of 61.4%, Up 300 Basis Points, Exceeding Expectations

Investors sentiment decreased to 0.95 in 2018 Q3. Its down 0.46, from 1.41 in 2018Q2. It dived, as 31 investors sold Insulet Corporation shares while 76 reduced holdings. 44 funds opened positions while 58 raised stakes. 62.28 million shares or 2.48% more from 60.77 million shares in 2018Q2 were reported. Strs Ohio holds 0% of its portfolio in Insulet Corporation (NASDAQ:PODD) for 2,485 shares. Federated Investors Pa invested in 0.05% or 211,100 shares. Moreover, Point72 Asset Mngmt Limited Partnership has 0.07% invested in Insulet Corporation (NASDAQ:PODD). Int holds 173,000 shares or 0.01% of its portfolio. Nelson Van Denburg Campbell Wealth Gru Limited Liability Corp invested in 0.01% or 250 shares. Nicholas Prtn Lp holds 42,726 shares. Hsbc Public, a United Kingdom-based fund reported 2,107 shares. Susquehanna Intl Limited Liability Partnership owns 146,844 shares. Guggenheim Capital Lc owns 5,977 shares for 0% of their portfolio. 71,201 were reported by State Of Wisconsin Board. Fmr Ltd stated it has 8.78M shares or 0.1% of all its holdings. 2,621 were reported by Old Fincl Bank In. Moreover, Mutual Of America Management Limited Co has 0.06% invested in Insulet Corporation (NASDAQ:PODD). Swiss National Bank & Trust holds 0.01% of its portfolio in Insulet Corporation (NASDAQ:PODD) for 102,200 shares. Cubist Systematic Strategies Llc holds 0% in Insulet Corporation (NASDAQ:PODD) or 182 shares.

More notable recent Insulet Corporation (NASDAQ:PODD) news were published by: Nasdaq.com which released: “Interesting PODD Put And Call Options For September 20th – Nasdaq” on January 25, 2019, also Nasdaq.com with their article: “3 Top Mid-Cap Stocks to Buy Right Now – Nasdaq” published on January 23, 2019, Streetinsider.com published: “Insulet (PODD) Announces Corinne Nevinny to Board – StreetInsider.com” on January 28, 2019. More interesting news about Insulet Corporation (NASDAQ:PODD) were released by: Nasdaq.com and their article: “Here’s Why Tandem Diabetes Care Is Dropping Today – Nasdaq” published on January 02, 2019 as well as Businesswire.com‘s news article titled: “Insulet Appoints Corinne Nevinny to Board of Directors – Business Wire” with publication date: January 28, 2019.